Cargando…
Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
BACKGROUND: Hepatocellular carcinoma (HCC) is among the commonest malignancies associated with significant cancer-related death. The identification of chemo-preventive agents following HCC treatments with the potential to lower the risk of HCC adverse course is intriguing. Metformin, a first-line ag...
Autores principales: | Cigrovski Berkovic, Maja, Giovanardi, Francesco, Mrzljak, Anna, Lai, Quirino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473950/ https://www.ncbi.nlm.nih.gov/pubmed/37664473 http://dx.doi.org/10.4239/wjd.v14.i8.1289 |
Ejemplares similares
-
The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis
por: Mrzljak, Anna, et al.
Publicado: (2022) -
Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018) -
Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018) -
Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis
por: Xu, Chunmei, et al.
Publicado: (2018) -
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)